Thanh N. Nguyen

Thanh N. Nguyen


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
TNThanh N. Nguyen
Thanh N. Nguyen
NBNeeraj Badjatia
Neeraj Badjatia
AMAtul Malhotra
Atul Malhotra
FGFiona K. Gibbons
Fiona K. Gibbons
MQMuddasir M. Qureshi
Muddasir M. Qureshi
SGSteven A. Greenberg
Steven A. Greenberg

21 July 2023 in Viruses
Verified
Journal Article
Open access
PDF file
JSJames E. Siegler
James E. Siegler
SDSavanna Dasgupta
Savanna Dasgupta
MAMohamad Abdalkader
Mohamad Abdalkader
MPMary Penckofer
Mary Penckofer
SYShadi Yaghi
Shadi Yaghi
TNThanh N. Nguyen
Thanh N. Nguyen
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in healthcare. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.

20 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
JSJames E. Siegler
James E. Siegler
SDSavanna Dasgupta
Savanna Dasgupta
MAMohamad Abdalkader
Mohamad Abdalkader
MPMary Penckofer
Mary Penckofer
SYShadi Yaghi
Shadi Yaghi
TNThanh N. Nguyen
Thanh N. Nguyen
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus, SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in health care. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.